Annual EBITDA
-$9.32 M
-$1.29 M-16.02%
December 31, 2023
Summary
- As of February 7, 2025, GLSI annual EBITDA is -$9.32 million, with the most recent change of -$1.29 million (-16.02%) on December 31, 2023.
- During the last 3 years, GLSI annual EBITDA has fallen by -$7.46 million (-401.25%).
- GLSI annual EBITDA is now -453.04% below its all-time high of -$1.69 million, reached on December 31, 2018.
Performance
GLSI EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$2.73 M
-$67.60 K-2.54%
September 30, 2024
Summary
- As of February 7, 2025, GLSI quarterly EBITDA is -$2.73 million, with the most recent change of -$67.60 thousand (-2.54%) on September 30, 2024.
- Over the past year, GLSI quarterly EBITDA has increased by +$107.00 thousand (+3.77%).
- GLSI quarterly EBITDA is now -1202.20% below its all-time high of -$209.50 thousand, reached on June 30, 2020.
Performance
GLSI Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$10.76 M
-$226.10 K-2.15%
September 30, 2024
Summary
- As of February 7, 2025, GLSI TTM EBITDA is -$10.76 million, with the most recent change of -$226.10 thousand (-2.15%) on September 30, 2024.
- Over the past year, GLSI TTM EBITDA has dropped by -$1.44 million (-15.40%).
- GLSI TTM EBITDA is now -929.86% below its all-time high of -$1.04 million, reached on September 30, 2020.
Performance
GLSI TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
GLSI EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -16.0% | +3.8% | -15.4% |
3 y3 years | -401.3% | +3.8% | -15.4% |
5 y5 years | -453.0% | +3.8% | -15.4% |
GLSI EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -103.0% | at low | -253.2% | +5.7% | -134.2% | at low |
5 y | 5-year | -401.3% | at low | -1202.2% | +5.7% | -929.9% | at low |
alltime | all time | -453.0% | at low | -1202.2% | +5.7% | -929.9% | at low |
Greenwich LifeSciences EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$2.73 M(+2.5%) | -$10.76 M(+2.1%) |
Jun 2024 | - | -$2.66 M(+4.9%) | -$10.53 M(+9.5%) |
Mar 2024 | - | -$2.54 M(-10.5%) | -$9.62 M(+3.2%) |
Dec 2023 | -$9.32 M(+16.0%) | -$2.84 M(+13.3%) | -$9.32 M(-0.6%) |
Sep 2023 | - | -$2.50 M(+43.2%) | -$9.38 M(+1.3%) |
Jun 2023 | - | -$1.75 M(-22.0%) | -$9.26 M(+11.8%) |
Mar 2023 | - | -$2.24 M(-22.6%) | -$8.29 M(+3.1%) |
Dec 2022 | -$8.04 M(+74.9%) | -$2.89 M(+21.5%) | -$8.04 M(+6.9%) |
Sep 2022 | - | -$2.38 M(+208.4%) | -$7.52 M(+25.3%) |
Jun 2022 | - | -$772.40 K(-61.2%) | -$6.00 M(+0.3%) |
Mar 2022 | - | -$1.99 M(-16.3%) | -$5.98 M(+30.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2021 | -$4.59 M(+147.0%) | -$2.38 M(+174.5%) | -$4.59 M(+36.4%) |
Sep 2021 | - | -$865.80 K(+15.1%) | -$3.37 M(+22.1%) |
Jun 2021 | - | -$752.50 K(+25.5%) | -$2.76 M(+24.5%) |
Mar 2021 | - | -$599.70 K(-47.9%) | -$2.22 M(+19.1%) |
Dec 2020 | -$1.86 M(-45.6%) | -$1.15 M(+349.6%) | -$1.86 M(+78.0%) |
Sep 2020 | - | -$256.00 K(+22.2%) | -$1.04 M(-7.0%) |
Jun 2020 | - | -$209.50 K(-14.0%) | -$1.12 M(-68.1%) |
Mar 2020 | - | -$243.70 K(-27.4%) | -$3.52 M(+7.4%) |
Dec 2019 | -$3.42 M(+102.9%) | -$335.60 K(+0.1%) | -$3.27 M(+11.4%) |
Sep 2019 | - | -$335.10 K(-87.1%) | -$2.94 M(+12.9%) |
Jun 2019 | - | -$2.60 M | -$2.60 M |
Dec 2018 | -$1.69 M | - | - |
FAQ
- What is Greenwich LifeSciences annual EBITDA?
- What is the all time high annual EBITDA for Greenwich LifeSciences?
- What is Greenwich LifeSciences annual EBITDA year-on-year change?
- What is Greenwich LifeSciences quarterly EBITDA?
- What is the all time high quarterly EBITDA for Greenwich LifeSciences?
- What is Greenwich LifeSciences quarterly EBITDA year-on-year change?
- What is Greenwich LifeSciences TTM EBITDA?
- What is the all time high TTM EBITDA for Greenwich LifeSciences?
- What is Greenwich LifeSciences TTM EBITDA year-on-year change?
What is Greenwich LifeSciences annual EBITDA?
The current annual EBITDA of GLSI is -$9.32 M
What is the all time high annual EBITDA for Greenwich LifeSciences?
Greenwich LifeSciences all-time high annual EBITDA is -$1.69 M
What is Greenwich LifeSciences annual EBITDA year-on-year change?
Over the past year, GLSI annual EBITDA has changed by -$1.29 M (-16.02%)
What is Greenwich LifeSciences quarterly EBITDA?
The current quarterly EBITDA of GLSI is -$2.73 M
What is the all time high quarterly EBITDA for Greenwich LifeSciences?
Greenwich LifeSciences all-time high quarterly EBITDA is -$209.50 K
What is Greenwich LifeSciences quarterly EBITDA year-on-year change?
Over the past year, GLSI quarterly EBITDA has changed by +$107.00 K (+3.77%)
What is Greenwich LifeSciences TTM EBITDA?
The current TTM EBITDA of GLSI is -$10.76 M
What is the all time high TTM EBITDA for Greenwich LifeSciences?
Greenwich LifeSciences all-time high TTM EBITDA is -$1.04 M
What is Greenwich LifeSciences TTM EBITDA year-on-year change?
Over the past year, GLSI TTM EBITDA has changed by -$1.44 M (-15.40%)